Carcinoembryonic antigen and cancer antigen 19-9 reflect the amount of glycoproteins and sugar chain antigens produced by tumor cells in the blood, whereas serum anti-p53 antibodies reflect the amount of antibodies produced by lymphocytes in response to P53 mutations harbored by tumor cells. Here, CEACAM5 is linked to neoplasm.